Indirect (Unconjugated) Bilirubin

When Indirect Bilirubin is HIGH

Elevated indirect (unconjugated) bilirubin has three principal mechanisms: increased haem production from haemolysis or ineffective erythropoiesis; reduced hepatic uptake of unconjugated bilirubin (as in Gilbert's syndrome or some medications); or impaired conjugation at the hepatic UGT1A1 enzyme step. Haemolytic causes produce the most dramatic elevations and are accompanied by low haemoglobin, elevated LDH, reduced haptoglobin, and reticulocytosis. Gilbert's syndrome produces a characteristically mild, intermittent elevation (typically 20-50 umol/L total bilirubin), worsened by fasting, stress, or illness, and is entirely benign.

Mild elevation (15-35 umol/L total bilirubin with predominantly indirect fraction) without anaemia or enzyme elevation is almost always Gilbert's syndrome or physiological variation. Higher values, or those accompanied by anaemia and fatigue, warrant investigation for haemolysis. The direct bilirubin fraction should be checked: if direct bilirubin is normal and indirect accounts for most of the total, the liver is functioning correctly and the problem lies upstream (excess production or impaired hepatic uptake).

Management steps:

• Compare total bilirubin fractions: indirect-predominant pattern with normal direct bilirubin narrows the differential to pre-hepatic causes
• Check haemoglobin, haematocrit, reticulocyte count, LDH, and haptoglobin to assess for haemolysis
• For Gilbert's syndrome: no treatment required. Avoid prolonged fasting before blood draws (fasting worsens Gilbert's elevation by 50-100%)
• Stay well hydrated: dehydration concentrates bilirubin and worsens apparent elevation
• Avoid additional haem-load triggers such as prolonged fasting, major surgery, or high-dose aspirin
• If haemolysis is confirmed with concurrent anaemia: investigate underlying cause with physician

PED-Specific Considerations: AAS-driven polycythaemia increases the rate of RBC destruction proportionally to the elevation in red cell mass. When haematocrit exceeds 52-54%, RBC lifespan shortens and haem catabolism accelerates, raising indirect bilirubin modestly (usually 15-25 umol/L). This is a direct consequence of excessive erythrocytosis, not liver toxicity, and resolves when haematocrit normalises through therapeutic phlebotomy or cycle cessation. EPO use produces the same mechanism at greater magnitude. MK-677 and GH do not meaningfully affect bilirubin fractions. If indirect bilirubin is elevated but haematocrit is normal, suspect Gilbert's syndrome or a concurrent mild haemolytic condition independent of PED use.

When Indirect Bilirubin is LOW

Very low indirect bilirubin is not clinically significant. It simply indicates low bilirubin production and efficient hepatic conjugation. No intervention is required.

PED-Specific Considerations: There is no PED-specific concern with low indirect bilirubin. Some users taking iron supplements or haematinics who experience iron-restricted erythropoiesis may have slightly lower bilirubin due to reduced haem turnover, but this is not a clinically relevant finding.

References:

• Bosma, P. J., Chowdhury, J. R., Bakker, C., et al. (1995). The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. New England Journal of Medicine, 333(18), 1171-1175. DOI: 10.1056/NEJM199511023331802
• Sassa, S. (2004). Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxidants and Redox Signalling, 6(5), 819-824. DOI: 10.1089/ars.2004.6.819
• Casella, A., Pantaleo, A., Liumbruno, G. M., & Ficarra, E. (2012). Red blood cell storage lesions. Clinical Chemistry and Laboratory Medicine, 50(1), 103-112. DOI: 10.1515/CCLM.2011.764
• Baggish, A. L., Weiner, R. B., Kanayama, G., et al. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991-2002. DOI: 10.1161/CIRCULATIONAHA.116.026945